{"transactions":[{"id":740142,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:11:42.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 35,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the Company's Board of Directors on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":122828,"source":{"system":"sec-edgar","filing":"0001104659-26-073460","document":"tm2617536-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926073460/tm2617536-3_4seq1.xml","form_type":"4"}},{"id":1113685,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:30:45.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the Company's Board of Directors on such dates."}],"balance_after":87828,"source":{"system":"sec-edgar","filing":"0001104659-25-058916","document":"tm2517867-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925058916/tm2517867-2_4seq1.xml","form_type":"4"}},{"id":1129158,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2025-05-30T11:18:41.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":3759929,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with an offer made pursuant to the Agreement and Plan of Merger, dated as of March 9, 2025 and as amended on April 14, 2025 (the \"Merger Agreement\"), in exchange for $4.10 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share. Each CVR represents the right to receive a payment ranging from $0.20 to $0.70 pursuant to certain milestone payments as defined in the Merger Agreement relating to the regulatory approval for cosibelimab in the European Union. The CVR milestone must be achieved within thirty-six (36) months after the date on which a marketing authorization application or equivalent application for cosibelimab receives a positive validation outcome by the European Medicines Agency."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-054690","document":"tm2516581-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465925054690/tm2516581-5_4seq1.xml","form_type":"4"}},{"id":1179389,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2025-04-03T19:27:55.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":15090,"price":4.04,"value":60963.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3759929,"source":{"system":"sec-edgar","filing":"0001104659-25-031813","document":"tm2511508-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465925031813/tm2511508-2_4seq1.xml","form_type":"4"}},{"id":1273731,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2025-02-11T21:00:21.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":10331,"price":3.15,"value":32542.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.14 to $3.16. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3775019,"source":{"system":"sec-edgar","filing":"0001104659-25-011656","document":"tm256253-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465925011656/tm256253-1_4seq1.xml","form_type":"4"}},{"id":1273730,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2025-02-11T21:00:21.000Z","date":"2025-02-07","kind":"sale","planned":false,"acquired":false,"shares":9233,"price":3.41,"value":31484.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.40 to $3.41. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3785350,"source":{"system":"sec-edgar","filing":"0001104659-25-011656","document":"tm256253-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465925011656/tm256253-1_4seq1.xml","form_type":"4"}},{"id":1289360,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2025-01-31T21:00:10.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-third on January 30, 2026, one-third on January 30, 2027, and January 30, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3794583,"source":{"system":"sec-edgar","filing":"0001104659-25-008258","document":"tm255136-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465925008258/tm255136-1_4seq1.xml","form_type":"4"}},{"id":1323995,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-12-20T21:30:54.000Z","date":"2024-12-20","kind":"gift","planned":false,"acquired":false,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 20, 2024, 900,000 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":2294583,"source":{"system":"sec-edgar","filing":"0001104659-24-130963","document":"tm2431781-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924130963/tm2431781-2_4seq1.xml","form_type":"4"}},{"id":1323994,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-12-20T21:30:54.000Z","date":"2024-12-19","kind":"sale","planned":false,"acquired":false,"shares":220230,"price":3.38,"value":744377.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 2,111,033 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.33 to $3.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3194583,"source":{"system":"sec-edgar","filing":"0001104659-24-130963","document":"tm2431781-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924130963/tm2431781-2_4seq1.xml","form_type":"4"}},{"id":1323993,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-12-20T21:30:54.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":602167,"price":3.87,"value":2330386.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 2,111,033 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.66 to $4.27. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":3414813,"source":{"system":"sec-edgar","filing":"0001104659-24-130963","document":"tm2431781-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924130963/tm2431781-2_4seq1.xml","form_type":"4"}},{"id":1328455,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-12-17T21:32:14.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":2077700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":4016980,"source":{"system":"sec-edgar","filing":"0001104659-24-129525","document":"tm2431396-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924129525/tm2431396-5_4seq1.xml","form_type":"4"}},{"id":1467148,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-06-28T20:01:14.000Z","date":"2024-06-26","kind":"gift","planned":false,"acquired":false,"shares":37890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On June 26, 2024, 37,890 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":1939280,"source":{"system":"sec-edgar","filing":"0001104659-24-076442","document":"tm2418524-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924076442/tm2418524-2_4seq1.xml","form_type":"4"}},{"id":1467147,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-06-28T20:01:14.000Z","date":"2024-06-26","kind":"sale","planned":false,"acquired":false,"shares":24610,"price":2.05,"value":50450.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 62,500 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.05 to $2.0504. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":1977170,"source":{"system":"sec-edgar","filing":"0001104659-24-076442","document":"tm2418524-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924076442/tm2418524-2_4seq1.xml","form_type":"4"}},{"id":1480898,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T20:21:20.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the board on such dates."}],"balance_after":57828,"source":{"system":"sec-edgar","filing":"0001104659-24-071284","document":"tm2416958-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465924071284/tm2416958-1_4seq1.xml","form_type":"4"}},{"id":1501836,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2024-05-24T21:00:17.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":1660000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-third on January 31, 2025, one-third on January 31, 2026 and one-third on January 31, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":2001780,"source":{"system":"sec-edgar","filing":"0001104659-24-065214","document":"tm2415549-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924065214/tm2415549-1_4seq1.xml","form_type":"4"}},{"id":1606822,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-03-01T20:31:14.000Z","date":"2024-02-28","kind":"gift","planned":false,"acquired":false,"shares":9056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 28, 2024, 9,056 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":341780,"source":{"system":"sec-edgar","filing":"0001104659-24-030149","document":"tm247659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924030149/tm247659-2_4seq1.xml","form_type":"4"}},{"id":1606821,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-03-01T20:31:14.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":5894,"price":2.06,"value":12141.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 14,950 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.06 to $2.075. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":350836,"source":{"system":"sec-edgar","filing":"0001104659-24-030149","document":"tm247659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924030149/tm247659-2_4seq1.xml","form_type":"4"}},{"id":1661481,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-02-02T20:10:17.000Z","date":"2024-02-01","kind":"gift","planned":false,"acquired":false,"shares":12950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 1, 2024, 12,950 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":356730,"source":{"system":"sec-edgar","filing":"0001104659-24-010265","document":"tm245141-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924010265/tm245141-2_4seq1.xml","form_type":"4"}},{"id":1661480,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2024-02-02T20:10:17.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":11900,"price":2.01,"value":23919.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 24,850 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.00 to $2.0104. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":369680,"source":{"system":"sec-edgar","filing":"0001104659-24-010265","document":"tm245141-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924010265/tm245141-2_4seq1.xml","form_type":"4"}},{"id":1661479,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2024-02-02T20:05:14.000Z","date":"2023-08-16","kind":"gift","planned":false,"acquired":false,"shares":12510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 16, 2023, 12,510 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":381580,"source":{"system":"sec-edgar","filing":"0001104659-24-010262","document":"tm245141-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924010262/tm245141-3_5seq1.xml","form_type":"5"}},{"id":1661478,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2024-02-02T20:05:14.000Z","date":"2023-02-24","kind":"gift","planned":false,"acquired":false,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2023, 42,000 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":381580,"source":{"system":"sec-edgar","filing":"0001104659-24-010262","document":"tm245141-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465924010262/tm245141-3_5seq1.xml","form_type":"5"}},{"id":1849948,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T12:16:54.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the board on such dates."}],"balance_after":27828,"source":{"system":"sec-edgar","filing":"0001104659-23-072607","document":"tm2319007-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465923072607/tm2319007-3_4seq1.xml","form_type":"4"}},{"id":1927840,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2023-04-04T20:30:59.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-fourth on March 31, 2024, one-fourth on March 31, 2025, one-fourth on March 31, 2026 and one-fourth on March 31, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":394090,"source":{"system":"sec-edgar","filing":"0001104659-23-041761","document":"tm2311770-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923041761/tm2311770-2_4seq1.xml","form_type":"4"}},{"id":1972851,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2023-03-03T20:00:56.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":5483,"price":5,"value":27415.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the vesting of 15,000 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.03. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":144090,"source":{"system":"sec-edgar","filing":"0001104659-23-028603","document":"tm238194-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923028603/tm238194-2_4seq1.xml","form_type":"4"}},{"id":1972850,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2023-03-03T20:00:56.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on February 27, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":149573,"source":{"system":"sec-edgar","filing":"0001104659-23-028603","document":"tm238194-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923028603/tm238194-2_4seq1.xml","form_type":"4"}},{"id":1972849,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2023-03-03T20:00:56.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":5548,"price":4.65,"value":25798.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 14,950 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.6833. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":134573,"source":{"system":"sec-edgar","filing":"0001104659-23-028603","document":"tm238194-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923028603/tm238194-2_4seq1.xml","form_type":"4"}},{"id":2032728,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2023-02-03T20:00:26.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":10261,"price":4.77,"value":48944.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 23,500 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.76 to $4.82. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":182121,"source":{"system":"sec-edgar","filing":"0001104659-23-010771","document":"tm235395-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923010771/tm235395-1_4seq1.xml","form_type":"4"}},{"id":2055593,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2023-01-12T20:05:26.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":3817,"price":6.749,"value":25760.933,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 13,475 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $6.60 to $6.90. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":192382,"source":{"system":"sec-edgar","filing":"0001104659-23-003529","document":"tm233206-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923003529/tm233206-1_4seq1.xml","form_type":"4"}},{"id":2055584,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"Common Stock","published_at":"2023-01-12T20:00:32.000Z","date":"2022-09-26","kind":"gift","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 26, 2022, shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust."},{"field":"shares","element":"transactionShares","label":"F2","text":"Checkpoint Therapeutics, Inc. effected a reverse stock split on December 6, 2022. The reported number gives effect to this reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":196199,"source":{"system":"sec-edgar","filing":"0001104659-23-003528","document":"tm233206-3_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465923003528/tm233206-3_5.xml","form_type":"5"}},{"id":2217154,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-07-01T21:30:35.000Z","date":"2022-06-23","kind":"sale","acquired":false,"shares":15000,"price":1.11,"value":16650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.11 to $1.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2562003,"source":{"system":"sec-edgar","filing":"0001104659-22-076976","document":"tm2220291-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922076976/tm2220291-1_4seq1.xml","form_type":"4"}},{"id":2217153,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-07-01T21:30:35.000Z","date":"2022-06-22","kind":"sale","acquired":false,"shares":12000,"price":1.09,"value":13080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.09 to $1.10. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2577003,"source":{"system":"sec-edgar","filing":"0001104659-22-076976","document":"tm2220291-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922076976/tm2220291-1_4seq1.xml","form_type":"4"}},{"id":2217152,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-07-01T21:30:35.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":21000,"price":1.09,"value":22890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2589003,"source":{"system":"sec-edgar","filing":"0001104659-22-076976","document":"tm2220291-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922076976/tm2220291-1_4seq1.xml","form_type":"4"}},{"id":2217151,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-07-01T21:30:35.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":228000,"price":1.09,"value":248520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2610003,"source":{"system":"sec-edgar","filing":"0001104659-22-076976","document":"tm2220291-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922076976/tm2220291-1_4seq1.xml","form_type":"4"}},{"id":2291772,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-04-13","kind":"sale","acquired":false,"shares":21258,"price":1.51,"value":32099.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2838003,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291771,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":14030,"price":1.77,"value":24833.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2859261,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291770,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":86353,"price":1.79,"value":154571.87,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2873291,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291769,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":117657,"price":1.85,"value":217665.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2959644,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291768,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-01-30","kind":"tax_withholding","acquired":false,"shares":31972,"price":2.46,"value":78651.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3077301,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291767,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-01-24","kind":"tax_withholding","acquired":false,"shares":143136,"price":2.19,"value":313467.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3109273,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291766,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-01-06","kind":"tax_withholding","acquired":false,"shares":53024,"price":2.77,"value":146876.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3252409,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2291765,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2022-04-22T20:31:04.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":302777,"price":3.11,"value":941636.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3305433,"source":{"system":"sec-edgar","filing":"0001104659-22-049156","document":"tm2213359-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922049156/tm2213359-1_4seq1.xml","form_type":"4"}},{"id":2305009,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-04-05T20:47:34.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025."}],"balance_after":15000,"derivative":{"exercise_price":7.02,"exercise_date":"2023-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-22-042817","document":"tm2211420-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465922042817/tm2211420-4_4seq1.xml","form_type":"4"}},{"id":2416338,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2022-02-02T19:00:38.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":455000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-fourth on January 31, 2023, one-fourth on January 31, 2024, one-fourth on January 31, 2025 and one-fourth on January 31, 2026"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3608210,"source":{"system":"sec-edgar","filing":"0001104659-22-010997","document":"tm225237-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465922010997/tm225237-1_4.xml","form_type":"4"}},{"id":2876568,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2021-02-05T20:16:41.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":48790,"price":3.4176,"value":166744.704,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 243,750 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted by the Company in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold in this transaction.  The range of prices for such transaction was $3.35 to $3.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares of restricted Common Stock, which vest over various time periods"}],"balance_after":3153210,"source":{"system":"sec-edgar","filing":"0001104659-21-013180","document":"tm215541-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465921013180/tm215541-2_4seq1.xml","form_type":"4"}},{"id":2876567,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK","published_at":"2021-02-05T20:16:41.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":70000,"price":3.5075,"value":245525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the vesting of 243,750 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted by the Company in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold in this transaction.  The range of prices for such transaction was $3.50 to $3.525. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes shares of restricted Common Stock, which vest over various time periods"}],"balance_after":3202000,"source":{"system":"sec-edgar","filing":"0001104659-21-013180","document":"tm215541-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465921013180/tm215541-2_4seq1.xml","form_type":"4"}},{"id":2912136,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2021-01-08T16:31:08.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":539000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-fourth on January 6, 2022, one-fourth on January 6, 2023, one-fourth on January 6, 2024 and one-fourth on January 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":3272000,"source":{"system":"sec-edgar","filing":"0001104659-21-002489","document":"tm212167-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465921002489/tm212167-2_4seq1.xml","form_type":"4"}},{"id":3249092,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2020-02-25T19:01:02.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":598000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-half on February 24, 2022, one-fourth on February 24, 2023, and one-fourth on February 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":2733000,"source":{"system":"sec-edgar","filing":"0001104659-20-024924","document":"tm2010923d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000110465920024924/tm2010923d1_form4.xml","form_type":"4"}},{"id":3686663,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President and Director"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2019-01-25T16:30:49.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":485000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-half on January 24, 2021, one-fourth on January 24, 2022 and one-fourth on January 24, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,000,000 shares of restricted stock that were granted on October 13, 2015, 325,000 shares of restricted stock that were granted on December 15, 2016, and 325,000 shares of restricted stock that were granted on January 30, 2018, all previously reported."}],"balance_after":2135000,"source":{"system":"sec-edgar","filing":"0001144204-19-002890","document":"tv511635_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000114420419002890/tv511635_form4.xml","form_type":"4"}},{"id":4081749,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2018-02-01T18:41:14.000Z","date":"2018-01-30","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: one-half on January 30, 2020, one-fourth on January 30, 2021 and one-fourth on January 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) 1,000,000 shares of restricted stock that were granted on October 13, 2015, as previously reported, and are scheduled to vest as follows: (i) 444,444 shares on October 13, 2019; (ii) 222,222 shares on the later of April 1, 2019 or the Company's achievement of market capitalization goals; and (iii) 333,334 shares on the Company's achievement of goals relating to corporate development transactions and/or FDA approval; (b) 325,000 shares of restricted stock that were granted on December 15, 2016, as previously reported, and are scheduled to vest as follows: (i) 243,750 shares on December 15, 2019; and (ii) 81,250 shares on December 15, 2020; and (c) the 325,000 shares of restricted stock that were granted on January 30, 2018, as reported herein."}],"balance_after":1650000,"source":{"system":"sec-edgar","filing":"0001144204-18-005239","document":"tv484690_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000114420418005239/tv484690_form4.xml","form_type":"4"}},{"id":4516919,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":38822,"kind":"person","name":"Oliviero James F III","position":1,"cik":"0001434718","reported_name":"Oliviero James F III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2016-12-19T18:05:22.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: One-half on December 15, 2018, one-fourth on December 15, 2019 and one-fourth on December 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares of restricted stock which vest over various time periods."}],"balance_after":1325000,"source":{"system":"sec-edgar","filing":"0001144204-16-140339","document":"v455312_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434718/000114420416140339/v455312_4.xml","form_type":"4"}}]}